Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
Primary objective:
- To determine if irbesartan 300mg is better than 150mg in protecting the kidneys in
hypertensive patients with diabetes and microalbuminuria.
Secondary objectives:
- To determine how well irbesartan 300mg is tolerated versus 150mg
- To determine the percentage of patients reaching the blood pressure target of 130/80
mmHg